LEK PHARMACEUTICALS D D - Slovenia 

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 1
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 1*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2015 8.366.433 0 2.631.738 1
2012 0 8.098.202 343.997 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ARISTOTLE UNIVERSITY OF THESSALONIKI1
BOEHRIGER INGELHEIM INTERNATIONAL1
CROMAPHARMA1
DECHEMA GESELLSCHAFT FUER CHEMISCHE TECHNIK UND BIOTECHNOLOGIE E V1
DEGUSSA1
EVONIK NUTRITION & CARE1
ITASUOMEN YLIOPISTO1
JOZEF STEFAN INSTITUTE1
KARLSRUHER INSTITUT FUER TECHNOLOGIE1
MERCK SERONO1
MILLIPORE SAS1
NANOMI BV1
NATIONAL INSTITUTE OF CHEMISTRY1
NATIONAL SYSTEMS1
SAGETIS BIOTECH SL1
SANDOZ1
THIOMATRIX FORSCHUNGS UND BERATUNGS1
UNIVERSIDAD DE NAVARRA1
UNIVERSITAET FUER BODENKULTUR WIEN1
UNIVERSITAET INNSBRUCK1
UNIVERSITY OF GREENWICH1
UNIVERSITY OF NEWCASTLE UPON TYNE1
UNIVERSITY OF WALES CARDIFF1

Constancy:

Total number of partners: 23
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 23
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2015-03-01Next-generation biopharmaceutical downstream process nextBioPharmDSPcoordinator8.366.4337
2012-04-01Mucus Permeating Nanoparticulate Drug Delivery Systems ALEXANDERparticipant8.098.20218

Alias institution names:

  • LEK PHARMACEUTICALS D D